Milestone Scientific Inc.
MLSSNYSECIK 855683HealthcareFiscal year ends Dec 31
Reports and events: 187 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2018-08-1416:25 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001437749-18-015605 |
| 2018-06-0109:05 ET | 8-K | 5.07 Shareholder vote results | 0001437749-18-011054 |
| 2018-05-1516:03 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001437749-18-009987 |
| 2018-04-3011:17 ET | DEF 14A | Proxy statementPeriod 2018-05-30 | 0001437749-18-008064 |
| 2018-04-0217:12 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001437749-18-006069 |
| 2017-12-1912:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-17-020886 |
| 2017-11-1416:23 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001437749-17-019359 |
| 2017-10-0616:51 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-17-016954 |
| 2017-10-0516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-17-016883 |
| 2017-09-0608:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-17-015601 |
| 2017-08-1416:08 ET | 10-Q | Quarterly reportPeriod 2017-06-30 | 0001437749-17-014710 |
| 2017-07-1716:15 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001437749-17-012717 |
| 2017-07-1116:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-17-012470 |
| 2017-06-1209:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-17-011120 |
| 2017-06-0716:22 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-17-010872 |
| 2017-06-0216:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-17-010542 |
| 2017-05-2513:13 ET | 8-K | 5.07 Shareholder vote results | 0001437749-17-010058 |
| 2017-05-1516:09 ET | 10-Q | Quarterly reportPeriod 2017-03-31 | 0001437749-17-009224 |
| 2017-04-1213:08 ET | DEF 14A | Proxy statementPeriod 2017-05-23 | 0001437749-17-006488 |
| 2017-03-3116:21 ET | 10-K | Annual reportPeriod 2016-12-31 | 0001437749-17-005780 |
| 2016-12-1610:13 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-16-043456 |
| 2016-12-1517:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-16-043435 |
| 2016-12-0216:53 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-16-042880 |
| 2016-11-0916:12 ET | 10-Q | Quarterly reportPeriod 2016-09-30 | 0001437749-16-041564 |
| 2016-08-2616:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-16-038124 |
| 2016-08-1116:13 ET | 10-Q | Quarterly reportPeriod 2016-06-30 | 0001437749-16-037178 |
| 2016-07-2111:40 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001437749-16-035444 |
| 2016-06-3017:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-16-638421 |
| 2016-06-3014:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-16-034685 |
| 2016-06-0109:36 ET | 8-K | 5.07 Shareholder vote results | 0001437749-16-033126 |
| 2016-05-1616:44 ET | 10-Q | Quarterly reportPeriod 2016-03-31 | 0001564590-16-019566 |
| 2016-04-2617:59 ET | 8-K | 3.02 Unregistered sale of equity | 0001193125-16-554455 |
| 2016-04-1512:44 ET | DEF 14A | Proxy statementPeriod 2015-05-25 | 0001193125-16-542842 |
| 2016-04-0617:26 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001564590-16-015942 |
| 2015-11-1213:11 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001564590-15-010524 |
| 2015-08-1316:22 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0001193125-15-290050 |
| 2015-06-1913:26 ET | 8-K | 5.07 Shareholder vote results | 0001193125-15-228507 |
| 2015-05-1416:52 ET | 10-Q | Quarterly reportPeriod 2015-03-31 | 0001564590-15-004325 |
| 2015-04-3013:19 ET | DEF 14A | Proxy statementPeriod 2015-06-17 | 0001193125-15-160633 |
| 2015-04-0120:10 ET | 10-K | Annual reportPeriod 2014-12-31 | 0001564590-15-002296 |
| 2015-02-2016:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-15-056295 |
| 2015-02-0917:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-15-039322 |
| 2014-11-1317:16 ET | 10-Q | Quarterly reportPeriod 2014-09-30 | 0001564590-14-005667 |
| 2014-08-1418:59 ET | 10-Q | Quarterly reportPeriod 2014-06-30 | 0001564590-14-003639 |
| 2014-06-0617:08 ET | 8-K | 5.07 Shareholder vote results | 0001193125-14-228929 |
| 2014-05-2717:18 ET | SC 13D | Ownership report, active investor | 0001193125-14-213161 |
| 2014-05-2717:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-14-213107 |
| 2014-05-1515:12 ET | DEF 14A | Proxy statementPeriod 2014-06-04 | 0001193125-14-201018 |
| 2014-05-1316:59 ET | 10-Q | Quarterly reportPeriod 2014-03-31 | 0001564590-14-002113 |
| 2014-04-1809:37 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-14-148592 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:14 ET. Listed shows no prices and gives no investment advice.